Clinical Evaluation of Oxidative Stress Biomarkers in Cirrhosis: Associations with Child–Pugh Class and Hepatic Encephalopathy

Background/Objectives: Oxidative stress contributes to the pathogenesis of cirrhosis, but its value as a clinical biomarker remains uncertain. Methods: We retrospectively analysed 90 patients with decompensated cirrhosis. Serum malondialdehyde (MDA) and 8-epi-prostaglandin F2α (8-iso-PGF2α) were measured at admission. Biomarker levels were compared between Child–Pugh classes B and C, across hepatic encephalopathy grades, and ascites severity, using Mann–Whitney, Kruskal–Wallis, and Spearman correlation tests. Results: Median MDA did not differ significantly between Child–Pugh classes B and C (2.67 [2.10–3.20] vs. 2.45 [1.98–3.05] μmol/L; p = 0.331), nor across ascites categories (p = 0.453). Similarly, 8-iso-PGF2α values did not vary between Child–Pugh classes (255.8 [220.0–310.0] vs. 250.1 [210.0–295.0] pg/mL; p = 0.784) or ascites groups (p = 0.828). Spearman analysis showed no significant correlations with albumin, INR, bilirubin, creatinine, or age, except for a non-significant trend with bilirubin (ρ = −0.18, p = 0.09). Importantly, MDA levels increased significantly across encephalopathy grades (p = 0.021), suggesting a link between systemic oxidative stress and neuropsychiatric impairment. Conclusions: In this clinical cohort, oxidative stress biomarkers did not provide discriminatory value for staging by Child–Pugh or ascites, but MDA was associated with encephalopathy severity. These findings highlight both the limitations and potential clinical relevance of oxidative stress markers in cirrhosis management.

• Publication year

  2025

• Venue

  Diagnostics

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/diagnostics15222853PMID 41300878PMCID 12650868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in Glutathione Redox Homeostasis in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review

  2024cited by this paper
• GC–MS and GC–MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations

  2023cited by this paper
• Oxidative Stress in Non-Alcoholic Fatty Liver Disease

  2022cited by this paper
• Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease

  2021cited by this paper
• Interrelation of inflammation and oxidative stress in liver cirrhosis

  2021cited by this paper
• The Roles of Various Prostaglandins in Fibrosis: A Review

  2021cited by this paper
• Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review

  2021cited by this paper
• Oxidative stress in alcohol-related liver disease

  2020cited by this paper
• THE EFFECT OF OXIDATIVE STRESS ON THE AUTONOMIC NERVOUS SYSTEM IN PATIENTS WITH LIVER CIRRHOSIS.

  2020cited by this paper
• Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma.

  2019cited by this paper
• NT-proBNP and Echocardiographic Parameters in Liver Cirrhosis: Correlations with Disease Severity

  2019cited by this paper
• Burden of liver diseases in the world.

  2019cited by this paper
• Increased serum malondialdehyde levels are associated with grey matter volume loss in patients with non-alcoholic cirrhosis.

  2019cited by this paper
• Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective.

  2018cited by this paper
• Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis.

  2016cited by this paper
• Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases

  2016cited by this paper
• The Role of Oxidative Stress and Antioxidants in Liver Diseases

  2015cited by this paper
• Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.

  2015cited by this paper
• Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF(2α)/PGF(2α) ratio distinguishes chemical from enzymatic lipid peroxidation.

  2015influential reference
• Pathogenesis of liver cirrhosis.

  2014cited by this paper
• Oxidative stress and redox signaling mechanisms of alcoholic liver disease: Updated experimental and clinical evidence

  2012cited by this paper
• Isoprostane generation and function.

  2011cited by this paper
• Role of oxidative stress in alcohol-induced liver injury

  2009cited by this paper
• F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications

  2008influential reference
• Free radicals and antioxidants in normal physiological functions and human disease.

  2007cited by this paper
• Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

  2006cited by this paper
• Oxidative stress, antioxidants, and vascular damage.

  2006cited by this paper
• A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

  2005cited by this paper
• Superoxide dismutase and total anti-oxidant levels in various forms of liver diseases.

  2002cited by this paper
• Pathogenesis of liver fibrosis: role of oxidative stress.

  2000cited by this paper
• Characterization of drugs as antioxidant prophylactics.

  1996cited by this paper

• No citing papers are available for this paper.